Striking the Right Balance Determines TB or Not TB
- PMID: 25339950
- PMCID: PMC4189424
- DOI: 10.3389/fimmu.2014.00455
Striking the Right Balance Determines TB or Not TB
Abstract
Mycobacterium tuberculosis continues to be one of the most successful pathogens on earth. Upon inhalation of M. tuberculosis by a healthy individual, the host immune system will attempt to eliminate these pathogens using a combination of immune defense strategies. These include the recruitment of macrophages and other phagocytes to the site of infection, production of cytokines that enhance the microbicidal capacity of the macrophages, as well as the activation of distinct subsets of leukocytes that work in concert to fight the infection. However, being as successful as it is, M. tuberculosis has evolved numerous strategies to subvert host immunity at virtual every level. As a consequence, one third of the world inhabitants carry M. tuberculosis, and tuberculosis continuous to cause disease in more than 8 million people with deadly consequences in well over 1 million patients each year. In this review, we discuss several of the strategies that M. tuberculosis employs to circumvent host immunity, as well as describe some of the mechanisms that the host uses to counter such subversive strategies. As for many other infectious diseases, the ultimate outcome is usually defined by the relative strength of the virulence strategies employed by the tubercle bacillus versus the arsenal of immune defense mechanisms of the infected host.
Keywords: Mycobacterium tuberculosis; immunity; inflammation; macrophage.
Similar articles
-
[Frontier of mycobacterium research--host vs. mycobacterium].Kekkaku. 2005 Sep;80(9):613-29. Kekkaku. 2005. PMID: 16245793 Japanese.
-
Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Front Immunol. 2014. PMID: 24795723 Free PMC article. Review.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
Crosstalk between Mycobacterium tuberculosis and the host cell.Semin Immunol. 2014 Dec;26(6):486-96. doi: 10.1016/j.smim.2014.09.002. Epub 2014 Oct 7. Semin Immunol. 2014. PMID: 25303934 Free PMC article. Review.
-
[Recent progress in mycobacteriology].Kekkaku. 2007 Oct;82(10):783-99. Kekkaku. 2007. PMID: 18018602 Japanese.
Cited by
-
mTORC2 is crucial for regulating the recombinant Mycobacterium tuberculosis CFP-10 protein-induced phagocytosis in macrophages.BMC Immunol. 2025 May 9;26(1):36. doi: 10.1186/s12865-025-00715-6. BMC Immunol. 2025. PMID: 40340685 Free PMC article.
-
Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.Front Cell Infect Microbiol. 2017 Oct 10;7:439. doi: 10.3389/fcimb.2017.00439. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 29067283 Free PMC article.
-
A potential target gene for the host-directed therapy of mycobacterial infection in murine macrophages.Int J Mol Med. 2016 Sep;38(3):823-33. doi: 10.3892/ijmm.2016.2675. Epub 2016 Jul 11. Int J Mol Med. 2016. PMID: 27432120 Free PMC article.
-
Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis.Semin Immunopathol. 2018 Nov;40(6):577-591. doi: 10.1007/s00281-018-0710-0. Epub 2018 Oct 10. Semin Immunopathol. 2018. PMID: 30306257 Review.
-
The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis.Front Microbiol. 2017 Nov 23;8:2284. doi: 10.3389/fmicb.2017.02284. eCollection 2017. Front Microbiol. 2017. PMID: 29218036 Free PMC article. Review.
References
-
- WHO and 104, F.S.N. (2014). Available form http://www.who.int/mediacentre/factsheets/fs104/en/
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials